HIPEC in Ovarian Cancer Is the Future… and Always Will Be? Results from a Spanish Multicentric Survey

SIMPLE SUMMARY: Treatment with intraperitoneal hyperthermic chemotherapy (HIPEC) has been criticized in ovarian cancer due to the lack of prospective and randomized clinical trials demonstrating its efficacy in improving outcomes. However, the publication of the Dutch clinical trial five years ago h...

Descripción completa

Detalles Bibliográficos
Autores principales: González Gil, Alida, Cerezuela Fernández-de Palencia, Álvaro, Gómez Ruiz, Álvaro Jesús, Gil Gómez, Elena, López Hernández, Francisco, Nieto Ruiz, Aníbal, Martínez, Jerónimo, Marhuenda, Iván, Cascales Campos, Pedro Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340748/
https://www.ncbi.nlm.nih.gov/pubmed/37444591
http://dx.doi.org/10.3390/cancers15133481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340748/
https://www.ncbi.nlm.nih.gov/pubmed/37444591
http://dx.doi.org/10.3390/cancers15133481

Ejemplares similares